Kodiak Sciences Company Insiders

KOD Stock  USD 6.67  0.12  1.83%   
Kodiak Sciences' insiders are aggressively selling. The analysis of the overall insider sentiment regarding Kodiak Sciences suggests that all insiders are panicking. Kodiak Sciences employs about 111 people. The company is managed by 9 executives with a total tenure of roughly 9 years, averaging almost 1.0 years of service per executive, having 12.33 employees per reported executive.
Hong Liang  President
Senior Vice President - Discovery Medicine

Kodiak Sciences' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-06-17John A BorgesonDisposed 2874 @ 2.75View
2024-06-12John A BorgesonDisposed 1558 @ 2.92View
Monitoring Kodiak Sciences' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kodiak Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.

Kodiak Sciences' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Kodiak Sciences' future performance. Based on our forecasts, it is anticipated that Kodiak will maintain a workforce of about 110 employees by January 2025.
 
Covid

Kodiak Sciences Management Team Effectiveness

The company has Return on Asset of (0.2672) % which means that on every $100 spent on assets, it lost $0.2672. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.715) %, meaning that it generated no profit with money invested by stockholders. Kodiak Sciences' management efficiency ratios could be used to measure how well Kodiak Sciences manages its routine affairs as well as how well it operates its assets and liabilities. As of December 2, 2024, Return On Tangible Assets is expected to decline to -0.57. The current year's Return On Capital Employed is expected to grow to -0.6. At present, Kodiak Sciences' Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 78.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 8.3 M.
As of December 2, 2024, Common Stock Shares Outstanding is expected to decline to about 42.4 M. The current year's Net Loss is expected to grow to about (285.4 M)

Kodiak Sciences Workforce Comparison

Kodiak Sciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 3,833. Kodiak Sciences holds roughly 111 in number of employees claiming about 2.9% of equities under Health Care industry.

Kodiak Sciences Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Kodiak Sciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Kodiak Sciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Kodiak Sciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.6
8
5
 248,519 
 12,951 
2023-06-01
1.3
13
10
 1,006,913 
 24,500 
2022-06-01
7.0
56
8
 1,634,228 
 21,323 
2022-03-01
4.5
36
8
 1,346,691 
 1,353,900 
2021-12-01
0.2
3
15
 20,850 
 42,576 
2021-09-01
2.1875
35
16
 926,647 
 171,889 
2021-06-01
1.24
31
25
 502,768 
 53,159 
2021-03-01
0.1481
4
27
 53,350 
 99,200 
2020-12-01
0.2857
10
35
 1,591,127 
 110,341 
2020-09-01
5.3077
69
13
 803,887 
 41,700 
2020-06-01
0.9091
20
22
 471,404 
 66,958 
2020-03-01
3.6667
44
12
 542,149 
 14,950 
2019-12-01
1.8333
11
6
 2,436,269 
 81,774 
2019-09-01
5.0
5
1
 442,001 
 1.00 
2019-03-01
1.0
1
1
 80,000 
 80,000 
2018-12-01
0.8889
16
18
 10,156,430 
 10,370,475 

Kodiak Sciences Notable Stakeholders

A Kodiak Sciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Kodiak Sciences often face trade-offs trying to please all of them. Kodiak Sciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Kodiak Sciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Hong LiangSenior Vice President - Discovery MedicineProfile
Tracy ChienVP ControllerProfile
Almas MScSenior OperationsProfile
Victor MDChairman, CoFounderProfile
Michael LouieSenior OfficerProfile
CPA MBACFO VPProfile
Pablo MDSenior DevelopmentProfile
Stephen RaillardSenior ManufacturingProfile
MD MPHChief OfficerProfile

About Kodiak Sciences Management Performance

The success or failure of an entity such as Kodiak Sciences often depends on how effective the management is. Kodiak Sciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Kodiak management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Kodiak management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.54)(0.57)
Return On Capital Employed(0.63)(0.60)
Return On Assets(0.54)(0.57)
Return On Equity(0.98)(0.93)
Please note, the presentation of Kodiak Sciences' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Kodiak Sciences' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Kodiak Sciences' management manipulating its earnings.

Kodiak Sciences Workforce Analysis

Traditionally, organizations such as Kodiak Sciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Kodiak Sciences within its industry.

Kodiak Sciences Manpower Efficiency

Return on Kodiak Sciences Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee2.3M
Net Loss Per Executive28.9M
Working Capital Per Employee2.2M
Working Capital Per Executive27.5M

Complementary Tools for Kodiak Stock analysis

When running Kodiak Sciences' price analysis, check to measure Kodiak Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kodiak Sciences is operating at the current time. Most of Kodiak Sciences' value examination focuses on studying past and present price action to predict the probability of Kodiak Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kodiak Sciences' price. Additionally, you may evaluate how the addition of Kodiak Sciences to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes